Sumatriptan Succinate
Product Images NDC 33261-662

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 33261-662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Sumatriptan Succinate 25mg 1)

Chemical structure of sumatriptan succinate, showing its molecular formula with specific functional groups and atomic connections.*

FDA Label Image

Sumatriptan-figure-1 (Sumatriptan Succinate 25mg 2)

A Kaplan-Meier plot showing the estimated probability of achieving initial headache response within 4 hours of treatment with oral sumatriptan at 25 mg, 50 mg, and 100 mg doses compared with placebo. The x-axis represents time in minutes from initial dose (0 to 240), and the y-axis shows the estimated probability of response (0% to 100%). The graph includes curves for placebo and each sumatriptan dose, indicating higher response probabilities for the sumatriptan doses over time.*

FDA Label Image

Sumatriptan-figure-2 (Sumatriptan Succinate 25mg 3)

Kaplan-Meier plot showing the estimated probability over 24 hours of patients taking a second dose of sumatriptan succinate tablets or other medication to treat migraine after an initial dose, comparing placebo with 25 mg, 50 mg, and 100 mg doses of sumatriptan succinate. The x-axis represents time in hours from the initial dose, and the y-axis represents the estimated probability of remediation or rescue. Data is from three pooled clinical trials.*

FDA Label Image

33261-0662_sumatriptan-succ_25mg (Sumatriptan Succinate 25mg 4)

Sumatriptan succinate 25 mg tablet packaging label, 9 tablets per pack, labeled by Aidarex Pharmaceuticals LLC. The label includes dosage strength, quantity, lot number, manufacturing and expiration dates, along with barcodes and regulatory identifiers. The label indicates that the tablets are film-coated. Manufactured by Sun Pharmaceutical Ind. Ltd. India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.